Literature DB >> 23392958

Current role of PET, CT, MR for invasive bladder cancer.

Nathan Lawrentschuk1, Sze Ting Lee, Andrew M Scott.   

Abstract

Imaging for urothelial cancer, particularly that located in the bladder, has generally been based on computed tomography (CT). However in more recent times the role of positron emission tomography-CT (PET-CT) has emerged and increasingly magnetic resonance (MR) imaging has become utilised. This concise review will outline the role of these modalities when dealing with muscle-invasive bladder cancer (MIBC).

Entities:  

Mesh：

Year:  2013        PMID： 23392958     DOI： 10.1007/s11934-013-0308-y

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   3.092


  19 in total

Review 1.  Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature.

Authors:  Gianluca Giannarini; Giuseppe Petralia; Harriet C Thoeny
Journal:  Eur Urol       Date:  2011-09-28       Impact factor: 20.096

2.  Initial results with (11)C-acetate positron emission tomography/computed tomography (PET/CT) in the staging of urinary bladder cancer.

Authors:  Heiko Schöder; Seng C Ong; Victor E Reuter; Shangde Cai; Eva Burnazi; Guido Dalbagni; Steven M Larson; Bernard H Bochner
Journal:  Mol Imaging Biol       Date:  2012-04       Impact factor: 3.488

3.  Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancer.

Authors:  Andrea B Apolo; Jamie Riches; Heiko Schöder; Oguz Akin; Alisa Trout; Matthew I Milowsky; Dean F Bajorin
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

4.  Prospective evaluation of MRI, ¹¹C-acetate PET/CT and contrast-enhanced CT for staging of bladder cancer.

Authors:  H A Vargas; O Akin; H Schöder; S Olgac; G Dalbagni; H Hricak; B H Bochner
Journal:  Eur J Radiol       Date:  2012-07-31       Impact factor: 3.528

5.  FDG-PET for preoperative staging of bladder cancer.

Authors:  O Drieskens; R Oyen; H Van Poppel; Y Vankan; P Flamen; L Mortelmans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-08-31       Impact factor: 9.236

6.  Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer.

Authors:  S Kosuda; P V Kison; R Greenough; H B Grossman; R L Wahl
Journal:  Eur J Nucl Med       Date:  1997-06

Review 7.  Role of magnetic resonance imaging in bladder cancer: current status and emerging techniques.

Authors:  David A Green; Matthieu Durand; Naveen Gumpeni; Michael Rink; Eugene K Cha; Pierre I Karakiewicz; Douglas S Scherr; Shahrokh F Shariat
Journal:  BJU Int       Date:  2012-04-13       Impact factor: 5.588

8.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

Review 9.  Radiologic imaging of patients with bladder cancer.

Authors:  Andrei S Purysko; Hilton M Leão Filho; Brian R Herts
Journal:  Semin Oncol       Date:  2012-10       Impact factor: 4.929

Review 10.  Bladder cancer.

Authors:  Donald S Kaufman; William U Shipley; Adam S Feldman
Journal:  Lancet       Date:  2009-06-10       Impact factor: 79.321
View more
  5 in total

Review 1.  [The role of the vesical imaging-reporting and data system (VI-RADS) for bladder cancer diagnostics-status quo].

Authors:  V Hechler; M Rink; D Beyersdorff; M Beer; A J Beer; V Panebianco; M Pecoraro; C Bolenz; G Salomon
Journal:  Urologe A       Date:  2019-12       Impact factor: 0.639

2.  The role and effect of FDG-PET/CT on patient management and restaging of bladder carcinoma.

Authors:  İsa Burak Güney; Kadir Alper Küçüker; Volkan İzol; Mustafa Kibar
Journal:  Turk J Urol       Date:  2019-11-01

Review 3.  Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors.

Authors:  Maria Lucia Iacovino; Chiara Carmen Miceli; Marco De Felice; Biagio Barone; Luca Pompella; Francesco Chiancone; Erika Di Zazzo; Giuseppe Tirino; Carminia Maria Della Corte; Ciro Imbimbo; Ferdinando De Vita; Felice Crocetto
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

Review 4.  The Role of Molecular Imaging in a Muscle-Invasive Bladder Cancer Patient: A Narrative Review in the Era of Multimodality Treatment.

Authors:  Vincenzo Cuccurullo; Giuseppe Danilo Di Stasio; Francesco Manti; Pierpaolo Arcuri; Rocco Damiano; Giuseppe Lucio Cascini
Journal:  Diagnostics (Basel)       Date:  2021-05-11

5.  Concordance in Biomarker Status Between Bladder Tumors at Time of Transurethral Resection and Subsequent Radical Cystectomy: Results of a 5-year Prospective Study.

Authors:  Niccolò M Passoni; Shahrokh F Shariat; Aditya Bagrodia; Franto Francis; Varun Rachakonda; Evanguelos Xylinas; Payal Kapur; Arthur I Sagalowsky; Yair Lotan
Journal:  Bladder Cancer       Date:  2016-01-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.